Publication Date
9-4-2022
Journal
BMC Pediatrics
DOI
10.1186/s12887-022-03560-3
PMID
36058901
PMCID
PMC9441063
PubMedCentral® Posted Date
9-4-2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Biliary Atresia, Choledocholithiasis, Cholestasis, Humans, Hyperbilirubinemia, Infant, Infant, Newborn, Infant, Newborn, Diseases, Jaundice, Neonatal, Liver Diseases, Male, Ursodeoxycholic Acid, Choledocholithiasis, Conjugated bilirubin, Biliary tree, Gallbladder, Case report
Abstract
BACKGROUND: Jaundice within the first 1-2 weeks of a neonate's life will generally self-resolve; however, if it lasts longer than this time frame it warrants further work up. Direct or conjugated hyperbilirubinemia can suggest neonatal cholestasis, which in turn reflects marked reduction in bile secretion and flow. The differential diagnosis for neonatal cholestasis is broad. Neonatal choledocholithiasis is a rare cause of neonatal cholestasis, but should be considered on the differential diagnosis for patients presenting with elevated conjugated bilirubin.
CASE PRESENTATION: We describe an infant who presented with neonatal cholestasis. He subsequently underwent work up for biliary atresia, as this is one of the more time-sensitive diagnoses that must be made in neonates with conjugated hyperbilirubinemia. He was ultimately found to have choledocholithiasis on magnetic resonance cholangiopancreatography. He was managed conservatively with optimizing nutrition and ursodeoxycholic acid therapy.
CONCLUSIONS: We found that conservative management, specifically optimizing nutrition and treating with ursodeoxycholic acid, can be a sufficient approach to facilitating resolution of the choledocholithiasis and conjugated hyperbilirubinemia.
Included in
Immunology of Infectious Disease Commons, Immunopathology Commons, Medical Immunology Commons, Pathology Commons, Pediatrics Commons